300
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Transferrin-Mediated Targeting of Bacteriophage HK97 Nanoparticles Into Tumor Cells

, , , &
Pages 55-68 | Published online: 23 Dec 2010

Bibliography

  • Hajitou A , PasqualiniR, ArapW: Vascular targeting: recent advances and therapeutic perspectives.Trends cardiovasc. Med.16(3), 80–88 (2006).
  • Heath J r, Davis ME: Nanotechnology and cancer. Annu. Rev. Med.59, 251–265 (2008).
  • Majoros IJ , WilliamsCR, Baker Jr: Current dendrimer applications in cancer diagnosis and therapy. Curr. Top. Med. Chem.8(14), 1165–1179 (2008).
  • Manchester M , SinghP: Virus-based nanoparticles (VNPS): platform technologies for diagnostic imaging.Adv. Drug Deliv. Rev.58(14), 1505–1522 (2006).
  • Soussan E , CasselS, BlanzatM, Rico-LattesI: Drug delivery by soft matter: matrix and vesicular carriers.Angew. Chem. Int. Ed. Engl.48(2), 274–288 (2009).
  • Xing Y , RaoJ: Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging.Cancer Biomark.4(6), 307–319 (2008).
  • Rae C , KoudelkaKJ, DestitoG, EstradaMN, GonzalezMJ, ManchesterM: Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPS).PLoS One3(10), e3315 (2008).
  • Fischlechner M , DonathE: Viruses as building blocks for materials and devices.Angew. Chem. Int. Ed. Engl.46(18), 3184–3193 (2007).
  • Choi VW , MccartyDM, SamulskiRJ: AAV hybrid serotypes: improved vectors for gene delivery.Curr. Gene Ther.5(3), 299–310 (2005).
  • Cockrell AS , KafriT: Gene delivery by lentivirus vectors.Mol. Biotechnol.36(3), 184–204 (2007).
  • Douglas JT : Adenovirus-mediated gene delivery: an overview.Methods Mol. Biol.246, 3–14 (2004).
  • Liepold L , AndersonS, WillitsDet al.: Viral capsids as MRI contrast agents.Magn. Reson. Med.58(5), 871–879 (2007).
  • Brown WL , MasticoRA, WuMet al.: RNA bacteriophage capsid-mediated drug delivery and epitope presentation.Intervirology45(4–6), 371–380 (2002).
  • Lewis JD , DestitoG, ZijlstraAet al.: Viral nanoparticles as tools for intravital vascular imaging.Nat. Med.12(3), 354–360 (2006).
  • Ren Y , WongSM, LimLY: Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin.Bioconjug. Chem.18(3), 836–843 (2007).
  • Singh P , PrasuhnD, YehRMet al.: Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.J. Control. Release120(1–2), 41–50 (2007).
  • Dhillon EK , DhillonTS, LaiAN, LinnS: Host range, immunity and antigenic properties of lambdoid coliphage hk97.J. Gen. Virol.50(1), 217–220 (1980).
  • Duda RL , HempelJ, MichelH, ShabanowitzJ, HuntD, HendrixRW: Structural transitions during bacteriophage HK97 head assembly.J. Mol. Biol.247(4), 618–635 (1995).
  • Gan L , ConwayJF, FirekBAet al.: Control of crosslinking by quaternary structure changes during bacteriophage HK97 maturation.Mol. Cell14(5), 559–569 (2004).
  • Ross PD , ChengN, ConwayJFet al.: Crosslinking renders bacteriophage HK97 capsid maturation irreversible and effects an essential stabilization.EMBO J.24(7), 1352–1363 (2005).
  • Loo L , GuentherRH, LommelSA, FranzenS: Encapsidation of nanoparticles by red clover necrotic mosaic virus.J. Am. Chem. Soc.129(36), 11111–11117 (2007).
  • Minten IJ , HendriksLJ, NolteRJ, CornelissenJJ: Controlled encapsulation of multiple proteins in virus capsids.J. Am. Chem. Soc.131(49), 17771–17773 (2009).
  • Duda RL , MartincicK, HendrixRW: Genetic basis of bacteriophage HK97 prohead assembly.J. Mol. Biol.247(4), 636–647 (1995).
  • Duda RL , MartincicK, XieZ, HendrixRW: Bacteriophage HK97 head assembly.FEMS Microbiol Rev17(1–2), 41–46 (1995).
  • Gertsman I , GanL, GuttmanMet al.: An unexpected twist in viral capsid maturation.Nature458(7238), 646–650 (2009).
  • Wikoff WR , LiljasL, DudaRL, TsurutaH, HendrixRW, JohnsonJE: Topologically linked protein rings in the bacteriophage HK97 capsid.Science289(5487), 2129–2133 (2000).
  • Steinmetz NF , EvansDJ, LomonossoffGP: Chemical introduction of reactive thiols into a viral nanoscaffold: a method that avoids virus aggregation.Chembiochem8(10), 1131–1136 (2007).
  • Wang Q , LinT, JohnsonJE, FinnMG: Natural supramolecular building blocks: cysteine-added mutants of cowpea mosaic virus.Chem. Biol.9(7), 813–819 (2002).
  • Qian ZM , LiH, SunH, HoK: Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.Pharmacol. Rev.54(4), 561–587 (2002).
  • Agarwal A , SarafS, AsthanaA, GuptaU, GajbhiyeV, JainNK: Ligand based dendritic systems for tumor targeting.Int. J. Pharm.350(1–2), 3–13 (2008).
  • Inoue T , CavanaughPG, SteckPA, BrunnerN, NicolsonGL: Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials.J. Cell Physiol.156(1), 212–217 (1993).
  • Bridges KR , SmithBR: Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.J. Clin. Invest.76(3), 913–918 (1985).
  • Faulk WP , HsiBL, StevensPJ: Transferrin and transferrin receptors in carcinoma of the breast.Lancet2(8191), 390–392 (1980).
  • Gatter KC , BrownG, TrowbridgeIS, WoolstonRE, MasonDY: Transferrin receptors in human tissues: Their distribution and possible clinical relevance.J. Clin. Pathol.36(5), 539–545 (1983).
  • Huebers HA , FinchCA: The physiology of transferrin and transferrin receptors.Physiol. Rev.67(2), 520–582 (1987).
  • Jiang YY , LiuC, HongMH, ZhuSJ, PeiYY: Tumor cell targeting of transferrin-PEG-TNF-α conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.Bioconjug. Chem.18(1), 41–49 (2007).
  • Macgillivray RT , MendezE, ShewaleJG, SinhaSK, Lineback-ZinsJ, BrewK: The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure.J. Biol. Chem.258(6), 3543–3553 (1983).
  • Bewley MC , TamBM, GrewalJet al.: X-ray crystallography and mass spectroscopy reveal that the N-lobe of human transferrin expressed in Pichia pastoris is folded correctly but is glycosylated on serine-32.Biochemistry38(8), 2535–2541 (1999).
  • Chamow SM , KoganTP, PeersDH, HastingsRC, ByrnRA, AshkenaziA: Conjugation of soluble cd4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.J. Biol. Chem.267(22), 15916–15922 (1992).
  • Sen Gupta S , KuzelkaJ, SinghP, LewisWG, ManchesterM, FinnMG: Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold.Bioconjug. Chem.16(6), 1572–1579 (2005).
  • Wu M , BrownWL, StockleyPG: Cell-specific delivery of bacteriophage-encapsidated ricin a chain.Bioconjug. Chem.6(5), 587–595 (1995).
  • Pettersen EF , GoddardTD, HuangCCet al.: UCSF Chimera – a visualization system for exploratory research and analysis.J. Comput. Chem.25(13), 1605–1612 (2004).
  • Gonzalez MJ , PlummerEM, RaeCS, ManchesterM: Interaction of cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.PLoS One4(11), e7981 (2009).
  • Koudelka KJ , DestitoG, PlummerEM, TraugerSA, SiuzdakG, ManchesterM: Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin.PLoS Pathog.5(5), e1000417 (2009).
  • Shriver LP , KoudelkaKJ, ManchesterM: Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.J. Neuroimmunol.211(1–2), 66–72 (2009).
  • Steinmetz NF , ManchesterM: Pegylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.Biomacromolecules10(4), 784–792 (2009).
  • Steinmetz NF , HongV, SpoerkeEDet al.: Buckyballs meet viral nanoparticles: Candidates for biomedicine.J. Am. Chem. Soc.131(47), 17093–17095 (2009).
  • Steinmetz NF , MertensME, TaurogREet al.: Potato virus X as a novel platform for potential biomedical applications.Nano Lett.10(1), 305–312 (2010).
  • Kaiser CR , FlennikenML, GillitzerEet al.: Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo.Int. J. Nanomedicine2(4), 715–733 (2007).
  • Prasuhn De J r, Singh P, Strable E, Brown S, Manchester M, Finn MG: Plasma clearance of bacteriophage qbeta particles as a function of surface charge. J. Am. Chem. Soc.130(4), 1328–1334 (2008).
  • Thurber GM , SchmidtMM, WittrupKD: Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.Adv. Drug Deliv. Rev.60, 1421–1434 (2008).
  • Li H , QianZM: Transferrin/transferrin receptor-mediated drug delivery.Med. Res. Rev.22(3), 225–250 (2002).
  • Wright CS : Structural comparison of the two distinct sugar binding sites in wheat germ agglutinin isolectin II.J. Mol. Biol.178(1), 91–104 (1984).
  • Kresse M , WagnerS, PfeffererD, LawaczeckR, ElsteV, SemmlerW: Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways.Magn. Reson. Med.40(2), 236–242 (1998).
  • Qing Y , ShuoW, ZhihuaWet al.: The in vitro antitumor effect and in vivo tumor-specificity distribution of human–mouse chimeric antibody against transferrin receptor.Cancer Immunol. Immunother.55(9), 1111–1121 (2006).
  • Sato Y , YamauchiN, TakahashiMet al.: In vivo gene delivery to tumor cells by transferrin–streptavidin–DNA conjugate.FASEB J.14(13), 2108–2118 (2000).
  • White S , TaetleR, SeligmanPA, RutherfordM, TrowbridgeIS: Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.Cancer Res.50(19), 6295–6301 (1990).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.